← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2002Last known activity
Feb 1, 2016
Timeline
2000s
- Jan 1, 2002
New Mexico Cancer Care Alliance— Founded
Drugs by trial phase (54 distinct, 42 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (36 own, 0 via acquisition)
Phase 1 (11 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Bile Duct Neoplasms
- Biliary Tract Neoplasms
- Body Weight
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Squamous Cell
- Cholangiocarcinoma
- Fallopian Tube Neoplasms
- Gallbladder Neoplasms
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Lung Diseases
- Lung Neoplasms
- Lymphoma
- Lymphoma, Non-Hodgkin
- Melanoma
- Multiple Myeloma
- Nausea
- Neoplasms
- Neoplasms, Plasma Cell
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Peritoneal Neoplasms
- Prostatic Neoplasms
- Recurrence
- Sarcoma
- Vomiting
Recent trials (43)
- NCT03941782Lead sponsorN/A—
- NCT02571725Lead sponsorPhase 1/Phase 2Feb 1, 2016
- NCT02720601Lead sponsorPhase 2Nov 1, 2015
- NCT02470299Lead sponsorN/AOct 1, 2015
- NCT01889420Lead sponsorPhase 1Jul 1, 2014
- NCT01765803Lead sponsorEarly Phase 1Jun 1, 2013
- NCT01821833Lead sponsorN/AFeb 1, 2013
- NCT01542047Lead sponsorPhase 1Aug 1, 2012
- NCT01607554Lead sponsorPhase 1/Phase 2Apr 1, 2012
- NCT01670799Lead sponsorEarly Phase 1Mar 1, 2012
- NCT01478308Lead sponsorPhase 2Jun 1, 2011
- NCT01275183Lead sponsorEarly Phase 1Dec 1, 2010
- NCT01202890Lead sponsorPhase 1Sep 1, 2010
- NCT01100242Lead sponsorPhase 2Apr 1, 2010
- NCT01100242Overall official - principal investigatorPhase 2Apr 1, 2010
Details
- Founded
- Albuquerque, NM, US Jan 1, 2002
- Last known activity
- Feb 1, 2016